MEDVi is a real U.S. telehealth company that offers weight-management services and access to prescription GLP-1 treatment through medical providers and partner pharmacies. However, the answer to “Is MEDVi legit?” is not a simple yes. In February 2026, the U.S. Food and Drug Administration issued MEDVi a warning letter over marketing claims involving compounded semaglutide and tirzepatide. The company also has a large number of consumer complaints involving billing, cancellations, refunds and medication delivery.
That does not prove MEDVi is a scam. It does mean consumers should understand exactly what they are buying, how the subscription works and how compounded GLP-1 drugs differ from FDA-approved branded medicines.
What Is MEDVi?
MEDVi operates an online weight-management program. Patients complete an intake process and, when appropriate, may be evaluated by a licensed clinician who decides whether prescription treatment is suitable.
MEDVi says it is not itself a pharmacy and does not manufacture the compounded medications offered through its program. Its website identifies pharmacy partners and says medical treatment is provided through affiliated medical groups and OpenLoop Health. These disclosures indicate that MEDVi is an operating telehealth platform rather than an anonymous online seller.
Why Did the FDA Warn MEDVi?
The most important regulatory issue is the FDA warning letter dated February 20, 2026. The FDA said it reviewed MEDVi’s website and found false or misleading claims concerning compounded semaglutide and tirzepatide products.
The agency said images and labeling could create the impression that MEDVi was the compounder of the drugs when it was not. The FDA also objected to statements such as “same active ingredient as” well-known products including Wegovy, Ozempic, Mounjaro and Zepbound because the claims could imply that the compounded products had been FDA-approved or evaluated for safety and effectiveness.
The FDA classified the products described in the letter as misbranded under the Federal Food, Drug, and Cosmetic Act and warned that failure to correct violations could result in further enforcement, including seizure or injunction.
Importantly, an FDA warning letter is not the same as a criminal conviction or a court finding that a company committed fraud. It is nevertheless a serious regulatory warning that consumers should consider.
Are MEDVi GLP-1 Medications FDA-Approved?
The compounded GLP-1 medications offered through MEDVi are not FDA-approved. MEDVi’s current website now states that compounded GLP-1 products are not evaluated by the FDA for safety, effectiveness or quality in the same way as an approved new drug.
This distinction is important. A compounded product may use an active ingredient associated with an approved drug, but that does not make the compounded medication identical to an FDA-approved brand-name product. Patients should ask which pharmacy will dispense the prescription, what formulation is being supplied and why a clinician considers it appropriate.
What Do MEDVi Reviews and Complaints Show?
Consumer feedback is mixed.
The Better Business Bureau lists MEDVi as not BBB accredited and shows hundreds of complaints, many involving service, recurring charges, cancellation requests, refunds and medication fulfillment. Its customer-review score is also low.
Trustpilot shows a very different picture. MEDVi has thousands of reviews and a rating above four stars, with many customers praising clinicians, nurses and appointment support. Trustpilot also notes that MEDVi invites customers to submit reviews.
The difference between the platforms is a good reason not to judge the company from one review score alone. BBB complaints are consumer allegations and do not automatically establish wrongdoing. Positive reviews likewise do not erase documented regulatory problems or billing disputes.
MEDVi Cancellation and Refund Policy
MEDVi’s subscription terms deserve careful attention. Its published policy says customers may cancel at any time, but cancellation generally must be requested at least 72 hours before the next billing date to avoid another charge.
For monthly subscriptions, MEDVi says it generally does not issue a refund for the month in which cancellation occurs or for earlier months. For plans charged for two or more months at once, the policy says refunds may be available for months in which medication was not shipped. Customers who are medically disqualified by the provider may also qualify for a refund.
Anyone cancelling should keep emails, portal messages, payment receipts and written confirmation of cancellation.
Red Flags Consumers Should Consider
Before signing up, consumers should pay attention to several issues:
- MEDVi received an FDA warning letter in February 2026 over marketing of compounded semaglutide and tirzepatide.
- The compounded GLP-1 drugs offered through the service are not FDA-approved.
- BBB records show a substantial volume of complaints, including billing and service disputes.
- The refund policy places meaningful limits on refunds for monthly subscribers.
- Customer experiences differ sharply across review platforms.
At the same time, MEDVi publicly provides a business address, customer-service contacts, information about its medical-provider structure and names of pharmacy partners. Those are important signs that it is an operating business, even though they do not eliminate the concerns above.
Final Verdict: Is MEDVi Legit?
MEDVi appears to be a legitimate operating telehealth company, but consumers should approach it with caution.
There is evidence of a real business structure, medical-provider relationships, pharmacy partners and a large customer base. However, the FDA’s February 2026 warning letter is a significant regulatory concern, and the number of BBB complaints involving billing, cancellations and fulfillment should not be ignored.
The best conclusion is that MEDVi should not simply be labelled a fake company or scam based on the available evidence. But “legitimate business” does not automatically mean “best choice” or “risk-free service.” Before paying, consumers should read the recurring-payment and refund terms, confirm whether the prescription is compounded, identify the dispensing pharmacy and make sure a licensed clinician has reviewed their medical history.